You are here

  • Home
  • Archive
  • Volume 79, Issue 10
  • Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin

Article info

Article menu

Download PDFPDF

Correspondence response
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Free

Authors

  • Antonis Fanouriakis Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece PubMed articlesGoogle scholar articles
  • George Bertsias Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece Laboratory of Autoimmunity-Inflammation, Institute of Molecular Biology and Biotechnology, Heraklion, Greece PubMed articlesGoogle scholar articles
  • Dimitrios T Boumpas Rheumatology and Clinical Immunology, 4th Department of Internal Medicine, "Attikon" University Hospital, Athens, Greece Laboratory of Autoimmunity and Inflammation, Biomedical Research Foundation of the Academy of Athens, Athens, Greece Joint Academic Rheumatology Program, Medical School, National and Kapodestrian University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Dimitrios T Boumpas, Medicine, National and Kapodestrian University of Athens, Athens 157 72, Greece; boumpasd{at}uoc.gr
View Full Text

Citation

Fanouriakis A, Bertsias G, Boumpas DT
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Annals of the Rheumatic Diseases 2020;79:e132.

Publication history

  • Received June 6, 2019
  • Accepted June 6, 2019
  • First published July 3, 2019.
Online issue publication 
September 14, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.